These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24937251)

  • 1. Expression of recombinant vaccines and antibodies in plants.
    Ko K
    Monoclon Antib Immunodiagn Immunother; 2014 Jun; 33(3):192-8. PubMed ID: 24937251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing immunogenicity of biopharmaceuticals by controlling critical quality attributes of proteins.
    van Beers MM; Bardor M
    Biotechnol J; 2012 Dec; 7(12):1473-84. PubMed ID: 23027660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyco-engineering of biotherapeutic proteins in plants.
    Ko K; Ahn MH; Song M; Choo YK; Kim HS; Ko K; Joung H
    Mol Cells; 2008 Jun; 25(4):494-503. PubMed ID: 18443408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sweet tooth of biopharmaceuticals: importance of recombinant protein glycosylation analysis.
    Lingg N; Zhang P; Song Z; Bardor M
    Biotechnol J; 2012 Dec; 7(12):1462-72. PubMed ID: 22829536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moss bioreactors producing improved biopharmaceuticals.
    Decker EL; Reski R
    Curr Opin Biotechnol; 2007 Oct; 18(5):393-8. PubMed ID: 17869503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots.
    Sivakumar G
    Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant glycans: friend or foe in vaccine development?
    Bosch D; Schots A
    Expert Rev Vaccines; 2010 Aug; 9(8):835-42. PubMed ID: 20673008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins.
    Hefferon KL
    Virology; 2012 Nov; 433(1):1-6. PubMed ID: 22979981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current achievements in the production of complex biopharmaceuticals with moss bioreactors.
    Decker EL; Reski R
    Bioprocess Biosyst Eng; 2008 Jan; 31(1):3-9. PubMed ID: 17701058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein production in moss bioreactors.
    Decker EL; Reski R
    Plant Cell Rep; 2012 Mar; 31(3):453-60. PubMed ID: 21960098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Targeting for Precision Glyco-Engineering: Production of Biopharmaceuticals Devoid of Plant-Typical Glycosylation in Moss Bioreactors.
    Decker EL; Wiedemann G; Reski R
    Methods Mol Biol; 2015; 1321():213-24. PubMed ID: 26082225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human rhabdomyosarcoma cell line TE671--Towards an innovative production platform for glycosylated biopharmaceuticals.
    Rosenlöcher J; Weilandt C; Sandig G; Reinke SO; Blanchard V; Hinderlich S
    Protein Expr Purif; 2015 Nov; 115():83-94. PubMed ID: 26272370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceuticals from plants: a multitude of options for posttranslational modifications.
    Warzecha H
    Biotechnol Genet Eng Rev; 2008; 25():315-30. PubMed ID: 21412360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.
    Shoji Y; Chichester JA; Jones M; Manceva SD; Damon E; Mett V; Musiychuk K; Bi H; Farrance C; Shamloul M; Kushnir N; Sharma S; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():41-50. PubMed ID: 21266846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current state-of-the-art in plant-based antibody production systems.
    Donini M; Marusic C
    Biotechnol Lett; 2019 Mar; 41(3):335-346. PubMed ID: 30684155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopharmaceutical production in plants: problems, solutions and opportunities.
    Gomord V; Chamberlain P; Jefferis R; Faye L
    Trends Biotechnol; 2005 Nov; 23(11):559-65. PubMed ID: 16168504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large scale production of recombinant human lactoferrin in the milk of transgenic cows.
    van Berkel PH; Welling MM; Geerts M; van Veen HA; Ravensbergen B; Salaheddine M; Pauwels EK; Pieper F; Nuijens JH; Nibbering PH
    Nat Biotechnol; 2002 May; 20(5):484-7. PubMed ID: 11981562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.